...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research

Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....

posted on Mar 23, 2020 06:11PM

CCD,

"Given the extensive library of molicules does RVX have any idea of which ones would be likely candidates or would it be more of a crap shoot?"

Is it not Apabetalone(RVX-208).

"Apabetalone prevents specialized proteins – called bromodomain and extraterminal domain (BET) proteins – from activating the expression of disease-associated and other genes, potentially disrupting SARS-CoV-2 reproduction while also limiting the entry of the virus into human cells."

 

Koo

Share
New Message
Please login to post a reply